nach oben

Erschienen in:

01.12.2007 | Article

The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients

verfasst von: P. Marchetti, M. Bugliani, R. Lupi, L. Marselli, M. Masini, U. Boggi, F. Filipponi, G. C. Weir, D. L. Eizirik, M. Cnop

Erschienen in: Diabetologia | Ausgabe 12/2007

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Pancreatic beta cells have highly developed endoplasmic reticulum (ER) due to their role in insulin secretion. Since ER stress has been associated with beta cell dysfunction, we studied several features of beta cell ER in human type 2 diabetes.

Methods

Pancreatic samples and/or isolated islets from non-diabetic controls (ND) and type 2 diabetes patients were evaluated for insulin secretion, apoptosis (electron microscopy and ELISA), morphometric ER assessment (electron microscopy), and expression of ER stress markers in beta cell prepared by laser capture microdissection and in isolated islets.

Results

Insulin release was lower and beta cell apoptosis higher in type 2 diabetes than ND islets. ER density volume was significantly increased in type 2 diabetes beta cells. Expression of alpha-mannosidase (also known as mannosidase, alpha, class 1A, member 1) and UDP-glucose glycoprotein glucosyl transferase like 2 (UGCGL2), assessed by microarray and/or real-time reverse transcriptase polymerase chain reaction (RT-PCR), differed between ND and type 2 diabetes beta cells. Expression of immunoglobulin heavy chain binding protein (BiP, also known as heat shock 70 kDa protein 5 [glucose-regulated protein, 78 kDa] [HSPA5]), X-box binding protein 1 (XBP-1, also known as XBP1) and C/EBP homologous protein (CHOP, also known as damage-inducible transcript 3 [DDIT3]) was not higher in type 2 diabetes beta cell or isolated islets cultured at 5.5 mmol/l glucose (microarray and real-time RT-PCR) than in ND samples. When islets were cultured for 24 h at 11.1 mmol/l glucose, there was induction of BiP and XBP-1 in type 2 diabetes islets but not in ND islets.

Conclusions/interpretation

Beta cell in type 2 diabetes showed modest signs of ER stress when studied in pancreatic samples or isolated islets maintained at physiological glucose concentration. However, exposure to increased glucose levels induced ER stress markers in type 2 diabetes islet cells, which therefore may be more susceptible to ER stress induced by metabolic perturbations.

American Diabetes Association (2007) Diagnosis and classification of diabetes mellitus. Diabetes Care 30:S42–S47CrossRef

Hossain P, Kawar B, El Nahas M (2007) Obesity and diabetes in the developing world—a growing challenge. N Engl J Med 356:213–215PubMedCrossRef

Yach D, Stuckler D, Brownell KD (2006) Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 12:62–66PubMedCrossRef

Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846PubMedCrossRef

Ferrannini E, Mari A (2004) Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 47:943–956PubMedCrossRef

Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116:1802–1812PubMedCrossRef

Weir GC, Bonner-Weir S (2004) Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53(Suppl 3):S16–S21PubMedCrossRef

Donath MY, Halban PA (2004) Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47:581–589PubMedCrossRef

Rhodes CJ (2005) Type 2 diabetes—a matter of beta-cell life and death? Science 307:380–384PubMedCrossRef

10.

Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97–S107PubMedCrossRef

11.

Cnop M, Ladriere L, Hekerman P et al (2007) Selective inhibition of eukaryotic translation initiation factor 2α dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic β-cell dysfunction and apoptosis. J Biol Chem 282:3989–3997PubMedCrossRef

12.

Oyadomari S, Araki E, Mori M (2002) Endoplasmic reticulum stress-mediated apoptosis in pancreatic β-cells. Apoptosis 7:335–345PubMedCrossRef

13.

Karaskov E, Scott C, Zhang L, Teodoro T, Ravazzola M, Volchuk A (2006) Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic β-cell apoptosis. Endocrinology 147:3398–3407PubMedCrossRef

14.

Schroder M, Kaufman RJ (2005) ER stress and the unfolded protein response. Mutat Res 569:29–63PubMed

15.

Shi Y, Taylor SI, Seng-Lai T, Sonenberg N (2003) When translation meets metabolism: multiple links to diabetes. Endocr Rev 24:91–101PubMedCrossRef

16.

Marciniak SJ, Ron D (2006) Endoplasmic reticulum stress signalling in disease. Physiol Rev 86:1133–1149PubMedCrossRef

17.

Wang J, Takeuchi T, Tanaka S et al (1999) A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest 103:27–37PubMedCrossRef

18.

Oyadomari S, Takeda K, Takiguchi M et al (2001) Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci USA 98:10845–10850PubMedCrossRef

19.

Cardozo AK, Ortis F, Storling J et al (2005) Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. Diabetes 54:452–461PubMedCrossRef

20.

Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL (2004) Free fatty acid and cytokines induce pancreatic β-cell apoptosis by different mechanisms: role of nuclear factor-κB and endoplasmic reticulum stress. Endocrinology 145:5087–5096PubMedCrossRef

21.

Araki E, Oyadomari S, Mori M (2003) Impact of endoplasmic reticulum stress pathway on pancreatic β-cells and diabetes mellitus. Exp Biol Med 228:1213–1217

22.

Iyer S, Korada M, Rainbow L et al (2004) Wolcott–Rallison syndrome: a clinical and genetic study of three children, novel mutation in EIF2AK3 and a review of the literature. Acta Paediatr 93:1195–1201PubMedCrossRef

23.

Harding HP, Zeng H, Zhang Y et al (2001) Diabetes mellitus and exocrine pancreatic dysfunction in perk−/− mice reveals a role for translational control in secretory cell survival. Mol Cell 7:1153–1163PubMedCrossRef

24.

Scheuner D, Vander Mierde D, Song B et al (2005) Control of mRNA translation preserves endoplasmic reticulum function in beta-cells and maintains glucose homeostasis. Nat Med 11:757–764PubMedCrossRef

25.

Laybutt DR, Preston AM, Akerfeldt MC et al (2007) Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 50:752–763PubMedCrossRef

26.

Huang C, Lin C, Haatajal L et al (2007) High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress-mediated beta cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 56:2016–2027PubMedCrossRef

27.

Del Guerra S, Lupi R, Marselli L et al (2005) Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 54(3):727–735PubMedCrossRef

28.

Marchetti P, Del Guerra S, Marselli L et al (2004) Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 89:5535–5541PubMedCrossRef

29.

Lupi R, Dotta F, Marselli L et al (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51:1437–1442PubMedCrossRef

30.

Fukui K, Yang Q, Cao Y et al (2005) The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. Cell Metab 2:373–384PubMedCrossRef

31.

Marselli L, Sgroi DC, Ahn Y-B, Sharma A, Bonner-Weir G, Weir G (2005) Laser capture microdissection provides marked enrichment of beta-cell tissue from human pancreas. Diabetes 54(Suppl 1):A403

32.

Ahn YB, Xu G, Marselli L et al (2007) Changes in gene expression in beta cells after islet isolation and transplantation using laser-capture microdissection. Diabetologia 50:334–342PubMedCrossRef

33.

Pirot P, Naamane N, Libert F et al (2007) Global profiling of genes modified by endoplasmic reticulum stress in pancreatic beta cells reveals the early degradation of insulin mRNAs. Diabetologia 50:1006–1014PubMedCrossRef

34.

Back Sh, Schroder M, Lee K, Zhang K, Kaufman RJ (2005) ER stress signalling by regulated splicing: IRE1/HAC1/XBP1. Methods 35:395–416PubMedCrossRef

35.

Deng S, Vatamaniuk M, Huang X et al (2004) Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 53:624–632PubMedCrossRef

36.

Lin JM, Fabregat ME, Gomis R, Bergsten P (2002) Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes. Diabetes 51:988–993PubMedCrossRef

37.

Fernandez-Alvarez J, Conget I, Rasschaert J, Sener A, Gomis R, Malaisse WJ (1994) Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients. Diabetologia 37:177–181PubMedCrossRef

38.

Ostenson CG, Gaisano H, Sheu L, Tibell A, Bartfai T (2006) Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes 55:435–440PubMedCrossRef

39.

Chehter EZ, Duarte MI, Takakura CF, Longo MA, Laudanna AA (2003) Ultrastructural study of the pancreas in AIDS. Pancreas 26:153–159PubMedCrossRef

40.

Junger E, Herberg L, Jeruschke K, Leiter EH (2002) The diabetes-prone NZO/Hl strain. II. Pancreatic immunopathology. Lab Invest 82:843–853PubMed

41.

Zuber C, Fan JY, Guhl B, Roth J (2004) Misfolded proinsulin accumulates in expanded pre-Golgi intermediates and endoplasmic reticulum subdomains in pancreatic beta cells of Akita mice. FASEB J 18:917–919PubMed

42.

Karaveg K, Siriwardena A, Tempel W et al (2005) Mechanism of class 1 (glycosylhydrolase family 47) α-mannosidases involved in N-glycan processing and endoplasmic reticulum quality control. J Biol Chem 280:16197–16207PubMedCrossRef

43.

Totani K, Ihara Y, Matsuo I, Koshino H, Ito Y (2005) Synthetic substrates for an endoplasmic reticulum protein-folding sensor, UDP-glucose: glycoprotein glucosyltransferase. Angew Chem Int Ed Engl 44:7950–7954PubMedCrossRef

44.

Dejgaard S, Nicolay J, Taheri M, Thomas DY, Bergeron JJ (2004) The ER glycoprotein quality control system. Curr Issues Mol Biol 6:29–42PubMed

45.

Oyadomari S, Mori M (2004) Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11:381–389PubMedCrossRef

46.

Loffler M, Bilban M, Reimers M, Waldhausl W, Stulnig TM (2006) Blood glucose-lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice. J Pharmacol Exp Ther 316:797–804PubMedCrossRef

47.

Kuchenmeister U, Kuhn G, Wegner J, Nurnberg G, Ender K (1999) Post mortem changes in Ca2+ transporting proteins of sarcoplasmic reticulum in dependence on malignant hyperthermia status in pigs. Mol Cell Biochem 195:37–46PubMedCrossRef

48.

Wang H, Kouri G, Wollheim CB (2005) ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity. J Cell Sci 118:3905–3915PubMedCrossRef

49.

Robertson RP (2004) Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 279:42351–42354PubMedCrossRef

50.

Lortz S, Tiedge M, Nachtwey T, Karlsen AE, Nerup J, Lenzen S (2000) Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes. Diabetes 49:1123–1130PubMedCrossRef

Titel: The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients
verfasst von: P. Marchetti
M. Bugliani
R. Lupi
L. Marselli
M. Masini
U. Boggi
F. Filipponi
G. C. Weir
D. L. Eizirik
M. Cnop
Publikationsdatum: 01.12.2007
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 12/2007
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-007-0816-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2007

The effect of birth order and parental age on the risk of type 1 and 2 diabetes among young adults

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms

Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes

Different mechanisms operating during different critical time-windows reduce rat fetal beta cell mass due to a maternal low-protein or low-energy diet

Impaired short-term blood pressure regulation and autonomic dysbalance in children with type 1 diabetes mellitus